Come up with a name for your new list and we'll add to it:
BioVidria raised a round of funding on January 02, 2014. Investors include
Emerging Innovations Fund.
BioVidria is commercializing high-sensitivity slides for DNA and protein microarrays. The technology utilizes a patented process to provide high surface area and optical transparency. This aims to off…